CEACAM21 and prostate carcinoma: The results showed that the rs6695584 enrichment in GG (RKO) is not higher than that in AG (DLD-1) in Fig. 1i, which may due to the heterozygous genotype.36,37 In line with our results, Gao et al.38 found that SNP rs11672691 also functioned as an enhancer for CEACAM21 in promoting prostate cancer aggressiveness.